The Big Catch-Up: a legacy that could last generations
Pandemic disruptions reversed decades of immunisation progress. A programme designed to catch-up, restore and strengthen immunisation programmes is shifting paradigms.
Leaving no one behind with immunisation
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world's deadliest diseases.
About us Explore our Progress Report
Latest VaccinesWork features
View moreNew study: HPV and measles vaccines top vaccine impact list
Researchers compared 14 vaccine programmes across 117 countries to estimate how many deaths and illnesses they prevent per 1,000 vaccinations.
Seen by a physician, but still not vaccinated: uncovering missed opportunities in Pakistan
An unnecessary disconnect between curative and preventive healthcare is leaving too many of Pakistan’s children at risk.
Better‑designed homes could cut three major child diseases by up to 44% – Tanzania trial
A three year study of Tanzanian children found that changing the way homes are designed can prevent diarrhoea, pneumonia and malaria, and help children grow taller.
VaccinesWork is an award-winning digital platform hosted by Gavi, covering news, features and explainers from every corner of global health and immunisation.
The Gavi Leap
The Gavi Leap
The Gavi Leap is the most ambitious reform agenda in global health, offering a blueprint for broader reform of the health and development architecture. Learn more about how Leap principles, such as country ownership, radical simplification and innovation, are already having a tangible impact on how immunisation is delivered in Gavi-supported countries.
Our work
Vaccine portfolio
Gavi supports vaccines against 20 infectious diseases, including Ebola, malaria, mpox and rabies.
Health systems support
Strong health and immunisation systems are vital to deliver vaccines to all the children who need them.
Latest Gavi news releases
View allGavi to propose new incentives aimed at advancing vaccine manufacturing in Africa
Gavi, the Vaccine Alliance today announced that it will seek Board approval to deploy US$189 million to support the rapid development of Africa’s vaccine manufacturing ecosystem.
The Government of Burundi introduces the HPV vaccine to protect girls and prevent cervical cancer
Under the leadership of the Ministry of Public Health and with the support of Gavi, UNICEF, and the WHO, Burundi has just launched, on April 29, 2026, the vaccine against HPV, which causes cervical cancer.
Marking World Immunization Week 2026, the International Rescue Committee (IRC) announced that, together with partners in the Gavi-funded REACH consortium, it has delivered more than 30 million life-saving vaccine doses in some of the world’s most…
The Vaccine Alliance
The Vaccine Alliance
Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.
Gavi 6.0 funding guidelines
Newly released funding guidelines outline the scope of Gavi’s vaccine and cash support for the 2026–2030 strategic period (Gavi 6.0), explain how countries should plan and prioritise their immunisation programmes within this support, clarify the requirements for the Gavi 6.0 country application and describe how to access other forms of assistance such as outbreak and emergency support.
Partner countries
Partner countries
Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower‑income countries.
Our donors
Our donors
As a public-private partnership, Gavi is funded by governments, foundations, institutions, organisations, corporations and private individuals.
